Evidence map›Paper›PMID 40045544›Full record

Trial reportMedical science monitor : international medical journal of experimental and clinical research2025

Wearable Devices as Tools for Better Hypertension Management in Elderly Patients.

Yangui Wang, Jinghua Tan, Jin Zhao, Tao Wang, Tingting Ma, Lili Shao, Wanju Sun

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yangui WangDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Jinghua TanDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Jin ZhaoDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Tao WangDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Tingting MaDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Lili ShaoDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.
Wanju SunDepartment of General Practice, Shanghai Pudong New Area People's Hospital, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Hypertension is a growing global health concern, particularly among the elderly, and is a significant contributor to cardiovascular and cerebrovascular diseases. Managing hypertension in elderly patients is particularly challenging, requiring continuous monitoring and strict adherence to treatment protocols. This study aimed to evaluate the effectiveness of integrated management strategies that utilize wearable devices in enhancing hypertension management for elderly patients. MATERIAL AND METHODS A total of 400 elderly patients with primary hypertension from the People's Hospital of Pudong New Area, Shanghai, and the Heqing Community Health Service Center were selected from September 2022 to November 2023. These patients were randomly assigned to either an experimental group or a control group. The experimental group used a chronic disease management platform based on wearable devices, which enabled real-time monitoring and personalized interventions. The control group received traditional hypertension management. RESULTS The experimental group achieved significantly better outcomes across multiple areas compared to the control group, including improved medication adherence, enhanced blood pressure control, and better quality of life encompassing overall health, physical, social, and emotional functions. Additionally, the experimental group showed enhanced knowledge of hypertension and superior self-management abilities, covering aspects such as diet, medication, and emotional management. CONCLUSIONS This study highlights the potential of wearable device-based chronic disease management platforms in significantly improving hypertension control, treatment adherence, quality of life, and self-management capabilities among elderly patients. The findings suggest that such technology-driven solutions can address the challenges of hypertension management in elderly populations, providing a critical tool for long-term disease management.

Indexed as

HypertensionWearable Electronic DevicesAgedAged, 80 and overAntihypertensive AgentsBlood PressureChinaFemaleHumansMaleMedication AdherenceMiddle AgedQuality of LifeAntihypertensive Agents

Identifiers

PMID40045544
PMCPMC11895399

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.